AAMC Home   Tomorrow's Doctors Tomorrow's Cures
  Home  Government Affairs   Newsroom   Meetings   Publications Shopping Cart   Site Map    

Home

Washington Highlights

Testimony & Correspondence

Top Issues:

 

Education

 

GME & IME Payments

HIPAA

Labor-HHS Appropriations

Research

Teaching Hospitals

Teaching Physicians

Veterans Affairs

Workforce

Government Affairs & Advocacy Site Map

Contact

 

Government Affairs Home > Teaching Hospitals > Clinical Trials

Medicare Coverage of Clinical Trials

Related Resources

The NCD calls for coverage of the “routine costs of qualifying clinical trials.” Clinical trials that are eligible for Medicare covered must meet three requirements: (1) the subject or purpose of the trial must be the evaluation of an item or service that falls within a Medicare benefit category and is not statutorily excluded from coverage; (2) the trial must have therapeutic intent; and (3) trials of therapeutic interventions must enroll patients with diagnosed disease rather than healthy volunteers; trials of diagnostic interventions may enroll healthy patients in order to have a proper control group.

In addition to these three criteria, a qualifying trial must have “desirable characteristics.” Trials deemed to be automatically qualified for coverage are: (1) trials funded by NIH, CDC, AHRQ, CMS, DOD and VA; (2) trials supported by centers or cooperative groups funded by the federal agencies listed in 1.; (3) trials conducted under an investigational new drug application (IND) reviewed by the FDA; and (4) drug trials that are exempt from having an IND, until other qualifying criteria rare in place. The Agency for Healthcare Research and Quality (AHRQ) was charged with developing qualifying criteria for “non-deemed” trials. Two public meetings were held in the fall of 2000 to solicit ideas about what should be included in the criteria. The AAMC provided comments. No criteria have yet been published.

Coverage for costs related to the use of investigational devices continues to be governed by the regulation found at 42 CFR §405.201-215.

An April 2001 CMS memorandum from the Office of Inspector General addressed two questions related to the NCD. The memorandum raised the possibility that the OIG could find that the waivers of copayments and deductibles—other than for financial need—or the provision of free items or services to Medicare beneficiaries enrolled in clinical trials, violate the antikickback statute or other laws.

Contact

Ivy Baer, Director & Regulatory Counsel
AAMC Health Care Affairs
ibaer@aamc.orc
(202) 828-0490

Contact Us    © 1995-2008 AAMC    Terms and Conditions    Privacy Statement